Keratinocyte cell lines derived from severe generalized recessive Epidermolysis Bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: Models to assess cell and gene therapies in vitro and in vivo

Experimental Dermatology

Volumn 22, Issue 9, 2013, Pages 601-603

  Chamorro, Cristina ^a   Almarza, David ^a   Duarte, Blanca ^a,b   Llames, Sara G ^b   Murillas, Rodolfo ^a,b   García, Marta ^b,c   Cigudosa, Juan C ^d   Espinosa Hevia, Luis ^d   Escámez, Maria José ^a,b,c   Mencía, Ángeles ^c   Meana, Álvaro ^b   García Escudero, Ramón ^a   Moro, Rosa ^a   Conti, Claudio J ^c,e   Del Río, Marcela ^a,b,c   Larcher, Fernando ^a,b,c  

^a CIEMAT   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^d Structural Biology and Biocomputing Programme   (Spain)

^e TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Cell lines; Genodermatoses; Keratinocytes; Viral oncogenes

Indexed keywords

COLLAGEN TYPE 7;

CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL LINE; CELL PROLIFERATION; CELL THERAPY; CHROMOSOME ANALYSIS; COLONY FORMING UNIT; EPIDERMOLYSIS BULLOSA; GENE MUTATION; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; LETTER; PHENOTYPE; RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA;

EID: 84882284982     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12203     Document Type: Letter

References (30)

1. Knaup J, Verwanger T, Gruber C et al. Exp Dermatol 2012: 21: 526-530.
2. van den Akker P C, Jonkman M F, Rengaw T et al. Hum Mutat 2011: 32: 1100-1107.
3. Escamez M J, Garcia M, Cuadrado-Corrales N et al. Br J Dermatol 2010: 163: 155-161.
4. Cuadrado-Corrales N, Sanchez-Jimeno C, Garcia M et al. BMC Med Genet 2010: 11: 139.
5. Uitto J. J Invest Dermatol 2012: 132: E29-E34.
6. Chamcheu J C, Wood G S, Siddiqui I A et al. Exp Dermatol 2012: 21: 481-489.
7. Mavilio F, Pellegrini G, Ferrari S et al. Nat Med 2006: 12: 1397-1402.
8. Naldini L. Nat Rev 2011: 12: 301-315.
9. Larcher F, Dellambra E, Rico L et al. Mol Ther 2007: 15: 1670-1676.
10. Mathor M B, Ferrari G, Dellambra E et al. Proc Natl Acad Sci U S A 1996: 93: 10371-10376.
11. Titeux M, Pendaries V, Zanta-Boussif M A et al. Mol Ther 2010: 18: 1509-1518.
12. Chen M, Kasahara N, Keene D R et al. Nat Genet 2002: 32: 670-675.
13. Morley S M, D'Alessandro M, Sexton C et al. Br J Dermatol 2003: 149: 46-58.
14. Chamcheu J C, Lorie E P, Akgul B et al. J Dermatol Sci 2009: 53: 198-206.
15. Mecklenbeck S, Compton S H, Mejia J E et al. Hum Gene Ther 2002: 13: 1655-1662.
16. Chipev C C, Steinert P M, Woodworth C D. J Invest Dermatol 1996: 106: 385-390.
17. Hawley-Nelson P, Vousden K H, Hubbert N L et al. EMBO J 1989: 8: 3905-3910.
18. Barbaro V, Testa A, Di Iorio E et al. J Cell Biol 2007: 177: 1037-1049.
19. Hennings H, Michael D, Cheng C et al. Cell 1980: 19: 245-254.
20. Cuthill S, Agarwal P, Sarkar S et al. Genes Chromosom Cancer 1999: 26: 304-311.
21. Del Rio M, Larcher F, Serrano F et al. Hum Gene Ther 2002: 13: 959-968.
22. Llames S G, Del Rio M, Larcher F et al. Transplantation 2004: 77: 350-355.
23. Pei X F, Sherman L, Sun Y H et al. Carcinogenesis 1998: 19: 1481-1486.
24. Sack G H Jr, Obie C. Exp Cell Res 1981: 134: 425-432.
25. Kulkarni Schmidt-Kastner P S, Heiden T, Tribukait B et al. Anticancer Res 1996: 16: 2681-2686.
26. Miquel C, Gagnoux-Palacios L, Durand-Clement M et al. Exp Cell Res 1996: 224: 279-290.
27. Stewart N, Bacchetti S. Virology 1991: 180: 49-57.
28. Cotsiki M, Lock R L, Cheng Y et al. Proc Natl Acad Sci U S A 2004: 101: 947-952.
29. Lee K M, Choi K H, Ouellette M M. Cytotechnology 2004: 45: 33-38.
30. Kiyono T, Foster S A, Koop J I et al. Nature 1998: 396: 84-88.